Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-10-05

Clinical Trial Update: Efficacy of Erenumab on Functional Impact of Migraine [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial reported results on the efficacy of erenumab for improving functional impact in migraine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • erenumab (erenumab)

Snippet

Sponsor: Merle Diamond | Conditions: Migraine | Phase 4 | Status: COMPLETED | Results posted: 2022-10-05